Impact of Intra-Aortic Balloon Counterpulsation on Prognosis of Patients with Acute Myocardial Infarction: A Meta-Analysis

Overview

Journal Acta Cardiol Sin

Date 2017 Nov 24

PMID 29167607

Citations 3

Authors

Zhi-Wei Gao

Ying-Zi Huang

Hong-Mei Zhao

Qing-Song Sun

Man Luo

Li-Qun Pang

Hong Sun

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed to evaluate the impact of intra-aortic balloon counterpulsation (IABP) on the prognosis of patients with acute myocardial infarction (AMI).

Methods: We identified and included in this study AMI cases treated with IABP from January 1970 to May 2014. For statistical analysis, we utilized RevMan 5.0 software.

Results: Fourteen RCTs with a total population of 2538 were included in this study. The in-hospital and 30-day mortality rate in the IABP group was not significantly lower than those in the non-IABP group. Subgroup analysis according to the type of revascularization, OR values of TT subgroup, PCI subgroup, and CABG subgroup were 0.64 (95% CI 0.25-1.61, p = 0.34), 0.85 (95% CI 0.65-1.11, p = 0.23) and 0.46 (95% CI 0.13-1.63, p = 0.23). And OR values of AMI patients in the before and after PCI subgroup were 0.43 (95% CI 0.21-0.91, p = 0.03) and 1.36 (95% CI 0.76-2.41, p = 0.30). The 6-month mortality in the IABP group was not significantly lower than that in the non-IABP group. And OR values of 6-month mortalities of the before and after PCI subgroup were 0.47 (95% CI 0.26-0.86, p = 0.01) and 1.40 (95% CI 0.57-3.45, p = 0.47).

Conclusions: IABP did not reduce the in-hospital and 30-day mortality of AMI patients, and did not reduce the 6-month mortality. But IABP used in AMI patients before PCI was associated not only with reduced in-hospital and 30-day mortality, but also reduced 6-month mortality.

Citing Articles

Application and Comparison of Different Prognostic Scoring Systems in Patients Who Underwent Cardiologist-Managed Percutaneous Cardiopulmonary Support.

Chien S, Lan W, Wu S, Chien C, Chien Y, Lo C Acta Cardiol Sin. 2020; 36(4):326-334.

PMID: 32675924 PMC: 7355122. DOI: 10.6515/ACS.202007_36(4).20191015A.

An Ideal Vascular Access in a Patient with Acute Coronary Syndrome and Cardiogenic Shock: The Arterial Cannula of Veno-Arterial Extracorporeal Membrane Oxygenation.

Liu K, Hsiao C Acta Cardiol Sin. 2019; 35(6):652-654.

PMID: 31879519 PMC: 6859106. DOI: 10.6515/ACS.201911_35(6).20190712A.

Initiation of Intra-Aortic Balloon Counterpulsation before Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction and High-Risk Features Might be Beneficial: Questions Remain.

Lin H, Wang T Acta Cardiol Sin. 2017; 33(6):578-580.

PMID: 29167608 PMC: 5694919. DOI: 10.6515/ACS20170327A.

References

Romeo F, Acconcia M, Sergi D, Romeo A, Muscoli S, Valente S . The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: a comprehensive meta-analysis. Am Heart J. 2013; 165(5):679-92. DOI: 10.1016/j.ahj.2013.02.020. View

Anderson R, Ohman E, Holmes Jr D, Col I, Stebbins A, Bates E . Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997; 30(3):708-15. DOI: 10.1016/s0735-1097(97)00227-1. View

Kono T, Morita H, Nishina T, Fujita M, Onaka H, Hirota Y . Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy. J Am Coll Cardiol. 1996; 28(4):876-81. DOI: 10.1016/s0735-1097(96)00240-9. View

Hochman J, Sleeper L, WEBB J, Sanborn T, White H, Talley J . Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999; 341(9):625-34. DOI: 10.1056/NEJM199908263410901. View

van t Hof A, Liem A, de Boer M, Hoorntje J, Suryapranata H, Zijlstra F . A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J. 1999; 20(9):659-65. DOI: 10.1053/euhj.1998.1348. View

Goldberg R, Spencer F, Gore J, Lessard D, Yarzebski J . Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009; 119(9):1211-9. PMC: 2730832. DOI: 10.1161/CIRCULATIONAHA.108.814947. View

Stone G, Marsalese D, Brodie B, Griffin J, Donohue B, Costantini C . A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial.... J Am Coll Cardiol. 1997; 29(7):1459-67. DOI: 10.1016/s0735-1097(97)00088-0. View

Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter J . Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med. 2009; 38(1):152-60. DOI: 10.1097/CCM.0b013e3181b78671. View

OGara P, Kushner F, Ascheim D, Casey Jr D, Chung M, de Lemos J . 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2012; 127(4):529-55. DOI: 10.1161/CIR.0b013e3182742c84. View

10.

Thiele H, Zeymer U, Neumann F, Ferenc M, Olbrich H, Hausleiter J . Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013; 382(9905):1638-45. DOI: 10.1016/S0140-6736(13)61783-3. View

11.

Ramanathan K, Farkouh M, Cosmi J, French J, Harkness S, Dzavik V . Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction. Am Heart J. 2011; 162(2):268-75. PMC: 3155687. DOI: 10.1016/j.ahj.2011.04.025. View

12.

Sterne J, Egger M, Smith G . Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001; 323(7304):101-5. PMC: 1120714. DOI: 10.1136/bmj.323.7304.101. View

13.

Ohman E, Nanas J, Stomel R, Leesar M, Nielsen D, ODea D . Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis. 2005; 19(1):33-9. DOI: 10.1007/s11239-005-0938-0. View

14.

Thiele H, Zeymer U, Neumann F, Ferenc M, Olbrich H, Hausleiter J . Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367(14):1287-96. DOI: 10.1056/NEJMoa1208410. View

15.

Byar D, Simon R, FRIEDEWALD W, Schlesselman J, DeMets D, Ellenberg J . Randomized clinical trials. Perspectives on some recent ideas. N Engl J Med. 1976; 295(2):74-80. DOI: 10.1056/NEJM197607082950204. View

16.

Higgins J, Thompson S, Deeks J, Altman D . Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60. PMC: 192859. DOI: 10.1136/bmj.327.7414.557. View

17.

Steg P, James S, Atar D, Badano L, Blomstrom-Lundqvist C, Borger M . ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33(20):2569-619. DOI: 10.1093/eurheartj/ehs215. View

18.

van Nunen L, van t Veer M, Schampaert S, Steerneman B, Rutten M, van de Vosse F . Intra-aortic balloon counterpulsation in acute myocardial infarction: old and emerging indications. Neth Heart J. 2013; 21(12):554-60. PMC: 3833909. DOI: 10.1007/s12471-013-0485-9. View

19.

Perera D, Stables R, Thomas M, Booth J, Pitt M, Blackman D . Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA. 2010; 304(8):867-74. DOI: 10.1001/jama.2010.1190. View

20.

Zeymer U, Hochadel M, Hauptmann K, Wiegand K, Schuhmacher B, Brachmann J . Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry. Clin Res Cardiol. 2012; 102(3):223-7. DOI: 10.1007/s00392-012-0523-4. View